Intrapancreatic Accessory Spleen Diagnosed As Neuroendocrine Tumor: The Dangers of False Positives and Their Implications in Subsequent Management.
Publication/Presentation Date
6-1-2021
Abstract
This case serves as a reminder to consider ectopic splenic tissue in the differential diagnosis of pancreatic masses. The literature shows a lack of awareness and overtreatment of this condition due to clinical and radiologic concern for malignancy, namely neuroendocrine tumors (NETs) identified on positron emission tomography (PET)-CT NETSPOT. Given the vast difference in management and prognosis of ectopic splenic anomalies and malignant neoplasms involving the pancreas, accurate diagnosis is imperative to avoid unnecessary invasive procedures such as Whipple or distal pancreatectomy and splenectomy, which are associated with increased morbidity and mortality.
Volume
13
Issue
6
First Page
15891
Last Page
15891
ISSN
2168-8184
Published In/Presented At
Kripalani, S., Patel, V., Joneja, U., Talwar, S., Parikh, M., Barshay, V., & Chaaya, A. (2021). Intrapancreatic Accessory Spleen Diagnosed As Neuroendocrine Tumor: The Dangers of False Positives and Their Implications in Subsequent Management. Cureus, 13(6), e15891. https://doi.org/10.7759/cureus.15891
Disciplines
Medicine and Health Sciences
PubMedID
34336412
Department(s)
Department of Pathology and Laboratory Medicine
Document Type
Article